Concentration of vasoactive intestinal peptide (VIP) and substance P (SP) in bronchi of patients with mild to moderate bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 583s Year: 2005
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis Source: Eur Respir J 2004; 24: 958-963 Year: 2004
Vasoactive intestinal peptide receptor 2 (VIPR2) in central airways of smokers Source: Eur Respir J 2002; 20: Suppl. 38, 88s Year: 2002
Functional studies on substance P in equine isolated bronchial airways Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002
Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma Source: Eur Respir J 2002; 19: 997-1002 Year: 2002
Inhalation of vasoactive intestinal peptide in pulmonary hypertension Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008
Serum level of VIP (vasoactive intestinal polypeptide) in patients with COPD in stable state and during exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 483s Year: 2001
Effects of neurokinins on nNOS expression in bronchial epithelial and inflammatory cells in airways of guinea pigs Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005
Expression vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006
Expression of cholinergic system components in the airway epithelium of COPD patients Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Change of secretory activity of goblet cells of bronchial epithelium in asthma patients in response to cold airway challenge Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
Examination of function and structure of respiratory cilia of adult COPD patients – comparison of nasal and bronchial mucosa Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Influence of endogenous corticosteroids on bronchial protective properties of β2 -agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
CCSP modulates inflammation in bronchial epithelium differentiated ex vivo from bronchial biopsy of COPD patients Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
Vitamin C, VIP (vasoactive intestinal polypeptide) and gastrin in the serum of COPD patients in stable state and during exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002
The role of vasoactive intestinal peptide in regulation of bronchial tone in children with asthma during the period of exacerbation Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015
Gastro-oesophageal reflux (GER) and airway responsiveness to methacholine, physical exercise and capsaicin in bronchial asthma: effect of gastric acid secretion inhibition Source: Eur Respir J 2002; 20: Suppl. 38, 50s Year: 2002
VIP (vasoactive intestinal polypeptide) and vitamin C in the serum of COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Analysis of airway mucin concentration in patients with pulmonary eosinophilia Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018 Year: 2018